Market Cycles, Not Headlines: What History Says About The 2025 Rally And What Comes Next

Even if equities rise in 2025 on optimism surrounding AI, investor psychology mirrors that of prior generations—driven by the ...
pharmaphorum

Jazz, Roche combo cleared by FDA for lung cancer

A regimen based on Jazz Pharma and PharmaMar's Zepzelca and Roche's Tecentriq has been approved in the US as a maintenance therapy for extensive-stage small-cell lung cancer (ES-SCLC). The approval ...
pharmaphorum

Umoja's in vivo cell therapy fast-tracked by FDA

One of the pioneers of in vivo cell therapy, Umoja Biopharma, has cleared another regulatory milestone after getting a fast-track designation from the FDA for its lead candidate for blood cancers, ...
India West

Chandrika Tandon: If You Don’t Do What You Can Do With Your Money, What’s The Point?

Most people you speak to have a job and probably a hobby making it easy to spread questions around whatever has made them successful. But Chandrika Tandon presents all kinds of challenges: One among ...